1. Clinical Overview
A triple-drug, fixed-dose combination (FDC) antihypertensive medication containing an angiotensin II receptor blocker (ARB), a dihydropyridine calcium channel blocker (CCB), and a thiazide-like diuretic. It provides synergistic blood pressure lowering through complementary mechanisms, targeting the renin-angiotensin-aldosterone system (RAAS), vascular smooth muscle calcium channels, and sodium/fluid balance. This FDC is indicated for patients with hypertension not adequately controlled on dual therapy, aiming to improve adherence and achieve stringent BP targets as per Indian guidelines.
| Onset | Duration | Bioavailability |
|---|---|---|
| Amlodipine: 6-12 hours; Telmisartan: 3 hours; Chlorthalidone: 2-6 hours. Significant antihypertensive effect is typically observed within 1-2 weeks of starting therapy. | Amlodipine: >24 hours; Telmisartan: >24 hours; Chlorthalidone: 24-72 hours. The combination provides sustained 24-hour blood pressure control with once-daily dosing. | Telmisartan: 42-58%; Amlodipine: 64-90%; Chlorthalidone: ~65%. |
2. Mechanism of Action
The combination exerts a multi-pronged attack on hypertension. Telmisartan selectively and competitively blocks the AT1 receptor, inhibiting the vasoconstrictor and aldosterone-secreting effects of angiotensin II. Amlodipine inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle, causing peripheral arterial vasodilation and reduced peripheral vascular resistance. Chlorthalidone inhibits sodium reabsorption in the distal convoluted tubule of the nephron, promoting natriuresis and diuresis, reducing plasma volume and peripheral resistance.
3. Indications & Uses
- Treatment of essential hypertension in adult patients whose blood pressure is not adequately controlled on any two of the following antihypertensive classes: ARB, CCB, or thiazide diuretic.
4. Dosage & Administration
Adult Dosage: One tablet (Telmisartan 40mg + Amlodipine 5mg + Chlorthalidone 12.5mg) orally once daily. Dose may be taken with or without food. Dose titration should have been done with individual components before switching to this FDC.
Administration: Swallow the tablet whole with a glass of water. Can be taken in the morning to prevent nocturia from the diuretic effect. Avoid taking in the evening. Do not crush or chew. If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double the dose.
5. Side Effects
Common side effects may include:
- Dizziness
- Headache
- Peripheral edema (swelling of ankles/feet - less common with this combination than with amlodipine alone)
- Fatigue/asthenia
- Flushing
- Palpitations
- Nausea
- Hypotension (especially initial doses)
- Increased urination
- Serum electrolyte disturbances (hypokalemia, hyponatremia, hypomagnesemia, hypercalcemia).
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Other Antihypertensives (Diuretics, Beta-blockers, ACEi) | Additive hypotensive effect. Risk of severe hypotension. | Major |
| Lithium | Chlorthalidone reduces renal clearance of lithium, increasing risk of lithium toxicity. | Major |
| NSAIDs (e.g., Ibuprofen, Diclofenac) | May reduce antihypertensive effect, increase risk of renal impairment, and worsen hyperkalemia (with telmisartan). | Major |
| Potassium supplements / Potassium-sparing diuretics (Spironolactone, Amiloride) / Salt substitutes | Increased risk of hyperkalemia due to telmisartan. | Major |
| Digoxin | Chlorthalidone-induced hypokalemia/hypomagnesemia may increase risk of digoxin toxicity. | Moderate |
| Corticosteroids (e.g., Prednisolone) | May antagonize the hypotensive effect and exacerbate hypokalemia. | Moderate |
| Antidiabetic drugs (Insulin, Sulfonylureas) | Chlorthalidone may decrease glucose tolerance, requiring dose adjustment. | Moderate |
| Strong CYP3A4 Inhibitors (e.g., Ketoconazole, Itraconazole, Clarithromycin, Ritonavir) | Increase amlodipine plasma concentration, risk of hypotension and edema. | Moderate |
| Simvastatin | Amlodipine may increase simvastatin exposure, slightly increasing risk of myopathy. | Moderate |
| Allopurinol | Increased risk of hypersensitivity reactions when combined with chlorthalidone. | Moderate |
7. Patient Counselling
- DO take the medication exactly as prescribed, at the same time each day.
- DO get your blood pressure checked regularly as advised by your doctor.
- DO maintain a regular follow-up for blood tests (potassium, kidney function).
- DO inform all your doctors and dentists that you are taking this medication.
- DO rise slowly from a sitting or lying position to avoid dizziness.
- DONT stop taking the medicine suddenly without consulting your doctor.
- DONT take over-the-counter NSAIDs (like ibuprofen) for pain/fever without asking your doctor.
- DONT use potassium supplements or salt substitutes without medical advice.
- DONT take a double dose if you miss one. Take it as soon as you remember, or skip it if it's almost time for the next dose.
8. Toxicology & Storage
Overdose: Primary manifestation is likely to be profound hypotension and reflex tachycardia. Symptoms may include dizziness, palpitations, flushing, marked peripheral edema, confusion, syncope, and shock. Electrolyte disturbances (hypokalemia, hyponatremia) from chlorthalidone overdose can lead to muscle weakness, cramps, arrhythmias, and seizures. Bradycardia and AV block are possible with severe amlodipine overdose.
Storage: Store below 30°C. Protect from light and moisture. Keep the tablet in the blister pack until use. Keep out of reach of children. Do not use after the expiry date printed on the pack.